• SENSEX 80,242.24
    -46.14 (--0.06%)
  • BANKNIFTY 55,087.15
    -304.10 (--0.55%)
  • Reliance Industr
    1,411.85 1,608.95(%)
  • Mazagon Dock
    3,149.70 3,149.70(%)
  • Bajaj Finance
    8,560.00 6,376.55(%)
  • Garden Reach Sh.
    1,855.00 890.05(%)
  • Cochin Shipyard
    1,575.50 1,169.00(%)
  • Tata Motors
    641.10 542.55(%)
  • Hind.Aeronautics
    4,466.00 3,045.95(%)
  • Paras Defence
    1,469.00 1,592.75(%)
  • Torrent Pharma.
    3,300.00 2,513.05(%)
  • Sonata Software
    446.50 762.00(%)
  • Data Pattern
    2,450.00 1,350.50(%)
  • IndusInd Bank
    843.10 1,550.00(%)
  • Samvardh. Mothe.
    131.75 107.30(%)
  • Bharat Electron
    312.50 221.00(%)
  • Trent
    5,130.00 4,197.50(%)
  • Varun Beverages
    507.45 419.40(%)
  • ICICI Bank
    1,415.10 1,051.50(%)
  • Vedanta
    423.20 527.00(%)
  • Hitachi Energy
    14,879.00 16,534.50(%)
  • Tech Mahindra
    1,510.60 1,807.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Jubilant Pharmova Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Jubilant Bhartia
  • BSE Code : 592.0
  • ISIN : INE700A01033
897.95 3 (0.36%)
  • As on 30 Apr 2025 (EOD)
  • Today’s Low

    866.30
  • Today’s High

    905.10
  • Open

    887.50
  • Perv Close

    894.70
  • 52W Low

    617.05
  • 52W High

    1,309.90

Key Indicators

  • P/E(TTM)

    290.39

  • Mar.Cap (₹Cr.)

    14,304.34

  • Div & Yield %

    0.56

  • Book Value(₹)

    144.30

  • Debt-Equity Ratio

    0.36

  • AGM Date

    30-Apr-2025

  • EPS

    3.09

  • P/E Ratio

    290.39

Financials Ratios

  • Debt-Equity Ratio

    0.68

  • Mar.Cap (₹Cr.)

    14,304.34

  • RONW (%)

    0.76

  • ROCE (%)

    6.37

Score Board

  • Equity (₹ in Cr.)

    15.93

  • BV (₹)

    144.30

  • Sales( ₹ in Cr.)

    784.70

  • NP (in Cr.)

    32.36

  • NP Var(%)

    -35.0

  • Div%

    500.0

  • CPS (₹)

    5.10

  • EPS (₹)

    2.00

  • Traded Value (₹ in Lakhs)

    14,293.99

  • 52 Week High

    1,309.90

  • 52 Week Low

    617.05

  • Price BSE

    897.0

  • Price NSE

    898.00

  • Market Capital( in Cr.)

    14,293.99

  • P/C Ratio

    177.20

  • P/E Ratio

    441.60

  • Price Vs.BV

    2.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 784.70 810.10 87.75 2,709.50 3,139.90 3,438.61
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 784.70 810.10 87.75 2,709.50 3,139.90 3,438.61
Other Income 103.40 137.90 125.87 47.88 173.23 78.00
Stock Adjustments -39.00 -3.50 0.00 -55.21 108.32 -46.74
Total Income 849.10 944.50 213.62 2,702.17 3,421.45 3,469.87
EXPENDITURE :            
Raw Materials 316.50 411.10 0.00 1,395.15 1,792.74 2,006.07
Power and Fuel Cost 68.40 75.40 9.27 280.40 369.20 358.28
Employee Cost 190.00 167.30 49.21 220.67 264.90 265.71
Other Manufacturing Expenses 59.60 49.00 0.91 216.91 269.07 255.24
Selling and Administration Expenses 88.60 93.00 26.84 100.02 143.14 138.82
Miscellaneous Expenses 6.10 7.70 8.29 14.07 39.96 46.87
Employee Benefit Expenses 190.00 167.30 49.21 220.67 264.90 265.71
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 729.20 803.50 94.54 2,227.23 2,879.02 3,070.99
Operating Profit 119.90 141.00 119.09 474.94 542.44 398.87
Interest 29.90 18.50 30.59 101.80 136.20 128.96
Gross Profit 90.00 122.50 88.50 373.14 406.24 269.91
Depreciation 48.30 43.20 6.25 99.97 107.40 86.48
Profit Before Tax 41.70 79.30 82.25 273.17 298.84 183.43
Current Tax 6.80 13.80 13.66 45.44 26.13 31.08
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 3.30 15.60 -9.91 13.25 -48.43 4.72
Reported Net Profit 31.60 49.90 78.50 214.48 321.14 147.63
Extraordinary Items -0.76 0.25 0.01 -0.19 -4.92 -4.47
Adjusted Net Profit 32.36 49.65 78.49 214.67 326.06 152.10
Adjustment below Net Profit 0.00 -0.70 0.25 -212.82 -3.49 -9.46
P & L Balance brought forward 1,123.60 1,154.00 1,154.92 1,153.26 986.93 951.70
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 79.60 79.60 79.64 0.00 151.32 102.95
P & L Balance carried down 1,075.60 1,123.60 1,154.03 1,154.92 1,153.26 986.93
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 500.00 500.00 500.00 500.00 500.00 450.00
Dividend Per Share(Rs) 5.00 5.00 5.00 5.00 5.00 4.50
Earnings Per Share-Unit Curr 1.99 3.14 4.93 13.46 20.16 9.27
Earnings Per Share(Adj)-Unit Curr 1.99 3.14 4.93 13.46 17.49 8.04
Book Value 149.34 151.86 80.47 80.51 163.67 146.91
Book Value(Adj)-Unit Curr 149.34 151.86 80.47 80.51 142.03 127.49

Shareholding Pattern

  • Promoter Group

    50.68%

  • Public Share Holding

    48.77%

  • Custodian

    0.56%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 5,230,455 3.28 5,230,455 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 5,000 5,000.00 5,000 5,000
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 5,235,455 3.29 5,235,455 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 73,583,176 46.20 73,583,176 6
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,898,425 1.19 1,898,425 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 75,481,601 47.39 75,481,601 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 2,645 0.00 2,045 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 27,432,895 17.22 27,432,895 151
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,158,875 1.36 2,158,875 6
Mutual Funds / UTI 5,826,631 3.66 5,826,631 18
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 3,233,599 2.03 3,233,599 19
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 38,654,645 24.27 38,654,045 196
2] Non Institution
Bodies Corporate 5,225,849 3.28 5,225,599 742
Clearing Members 325,672 0.20 325,672 26
Directors of their Relatives 2,794 0.00 2,794 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,887,348 1.18 1,866,193 2,593
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 820,859 0.52 820,859 1,618
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 10,472,000 6.57 10,472,000 3
Individuals holding nominal share capital up to Rs. 1 lakh 17,799,205 11.17 17,426,365 91,225
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 18,676 0.01 18,676 9
Others 1,993,153 1.25 1,993,153 1
Sub Total 39,025,028 24.50 38,630,783 96,317
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 884,410 0.56 884,410 1
Total Shares held by Custodians and against which Depository Receipts have been issued 884,410 0.56 884,410 1
Grand Total ( A + B + C ) 159,281,139 100.00 158,886,294 96,526

Company Background

Jubilant Pharmova LtdPharmaceuticals - Indian - Bulk Drugs

  • Jubilant Pharmova Ltd
  • BSE Code : 592.0
  • ISIN : INE700A01033
  • Incorporation Year

    1978

  • Registered Office

    Bhartiagram Gajraula
    , Amroha,
    Uttar Pradesh-244223

  • Telephone

    91-5924-267200

  • FAX

    91-5924-4264895/96

  • Chairman

    Shyam S Bhartia

  • Managing Director

    Priyavrat Bhartia

  • Company Secretary

    Naresh Kapoor

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Alankit Assignments Ltd
    Alankit Heights ,
    1E/13 Jhandewalan Ex,
    Mumbai - New Delhi-110055

Jubilant Pharmova Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Jubilant Pharmo 897.30 888.10 784.70 375.44 2.57
Abbott India 29,876.95 6,097.18 5,848.91 47.58 44.71
Astrazeneca Phar 8,665.50 1,330.33 1,295.53 223.40 33.26
P & G Health Ltd 5,072.65 1,166.89 1,151.26 35.59 39.76
Glaxosmi. Pharma 2,959.45 3,530.73 3,407.25 58.85 44.44
Cipla 1,549.65 17,645.00 16,574.34 26.57 20.10
Amrutanjan Healt 692.80 437.58 421.23 40.61 20.84
Guj. Themis Bio. 272.65 174.19 169.82 56.45 44.82
Fermenta Biotec. 260.70 315.24 307.09 24.71 4.10
Bliss GVS Pharma 119.00 638.96 605.46 27.23 11.19
Ambalal Sarabhai 36.46 11.70 3.81 15.58 1.92